Cancer / Tumour Markers

Checks breast and ovarian tumor markers to help with early detection of these cancers in women.

Measures the CA 15.3 tumour marker to help monitor breast cancer treatment and progression.

Measures AFP protein to help check for liver cancer and monitor certain tumors.

Measures the CEA tumour marker to help monitor colon and other cancers during treatment.

Checks for hidden blood in the stool to help spot bleeding in the gut and screen for colon cancer.

Measures the ratio of kappa and lambda light chains in blood to help assess immune and bone-marrow disorders.

Measures free kappa antibody chains to help detect and monitor multiple myeloma and plasma cell disorders.

Measures beta-2 microglobulin to help detect kidney damage or monitor certain conditions.

Measures free lambda antibody chains to help detect and monitor multiple myeloma and amyloidosis.

Checks male cancer markers with health tests to help detect early signs of cancer in men.

Checks key male cancer markers to help detect early signs of prostate and other cancers.

Measures the CA-125 tumour marker to help monitor ovarian cancer and related conditions.

Measures HE4, a marker often raised in ovarian cancer, to help detect and monitor the disease.

Combines CA-125 and HE4 results to help assess the risk that an ovarian mass is cancerous.

Measures the CA 19.9 tumour marker to help track pancreatic and other related cancers.

Measures the free portion of PSA to help tell apart prostate cancer risk from a non-cancerous enlarged prostate.

Measures PSA from the prostate gland to help screen for prostate problems in men.

Checks female cancer markers alongside health tests to help detect early signs of cancer in women.

Checks multiple tumor markers to screen for common women's cancers including ovarian, breast and endocrine.

Checks key female cancer markers to help detect early signs of common cancers in women.

Checks six cancer markers to screen for common women's cancers like ovarian, breast and endocrine.

Checks tumor markers with HE4 and the ROMA Index to screen for ovarian, breast and endocrine cancers in women.